U.S. National Government Hospitals Pricing Database 2024
September 25, 2024 08:32 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "U.S. Government Hospitals Pricing Database - National" database has been added to ResearchAndMarkets.com's offering. The U.S. Government-Owned...
Bio Plasticizers Market to Surpass USD 5.90 Billion by 2032, Predicted CAGR of 9.0% | Polaris Market Research
September 25, 2024 08:31 ET
|
Polaris Market Research & Consulting LLP
New York, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Market Outlook: Polaris Market Research analyzes that the market for bio plasticizers is anticipated to witness robust growth in the coming years....
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
September 25, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
September 25, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
DENVER, Sept. 25, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
Structural Health Monitoring Market to Surpass Market Valuation of USD 5.32 Billion by 2031 | SkyQuest Technology
September 25, 2024 08:30 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Structural Health Monitoring Market will reach a value of USD 5.32 Billion by 2031, with a CAGR of 10.30% during...
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
September 25, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies based on a...
Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split
September 25, 2024 08:30 ET
|
Sonnet BioTherapeutics Holdings, Inc.
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted...
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety
September 25, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
KULR Secures Expanded U.S. Army Battery Contract to $2.4M, Paving Way for KULR ONE Guardian Battery Production in 2025
September 25, 2024 08:30 ET
|
KULR Technology Group, Inc.
(NYSE American: KULR) today announced that it is on track to successfully complete its initial engagement with the United States Army by Q3 2024
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
September 25, 2024 08:30 ET
|
Entera Bio Ltd.; OPKO Health, Inc.
JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (Entera), a leader in the development of orally delivered peptides, and OPKO Health, Inc. (NASDAQ: OPK) (OPKO)...
- September 25, 2024 08:30 ET RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
- September 25, 2024 08:30 ET PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month